Wiley Bros. Aintree Capital, LLC Idexx Laboratories Inc Transaction History
Wiley Bros. Aintree Capital, LLC
- $12.5 Billion
- Q2 2025
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 5,927 shares of IDXX stock, worth $3.73 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,927
Previous 3,088
91.94%
Holding current value
$3.73 Million
Previous $1.3 Million
145.22%
% of portfolio
0.03%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding IDXX
# of Institutions
1,411Shares Held
75.2MCall Options Held
177KPut Options Held
226K-
Vanguard Group Inc Valley Forge, PA9.88MShares$6.22 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$6.05 Billion0.11% of portfolio
-
State Street Corp Boston, MA3.55MShares$2.24 Billion0.07% of portfolio
-
Terry Smith Fundsmith LLP | London, X02.64MShares$1.66 Billion6.2% of portfolio
-
Geode Capital Management, LLC Boston, MA2.46MShares$1.55 Billion0.1% of portfolio
About IDEXX LABORATORIES INC
- Ticker IDXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 83,253,696
- Market Cap $52.4B
- Description
- IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...